Refining the estimation of illicit drug consumptions from wastewater analysis: Co-analysis of prescription pharmaceuticals and uncertainty assessment

Water Research

Volumn 45, Issue 15, 2011, Pages 4437-4448

  Lai, Foon Yin ^a   Ort, Christoph ^a,b   Gartner, Coral ^c   Carter, Steve ^d   Prichard, Jeremy ^e   Kirkbride, Paul ^f   Bruno, Raimondo ^e   Hall, Wayne ^c   Eaglesham, Geoff ^a,d   Mueller, Jochen F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QUEENSLAND HEALTH   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

^f Australian Federal Police   (Australia)

Author keywords

Australia; Error propagation; Estimated population; LC MS MS; Normalization

Indexed keywords

CATCHMENTS; DRUG PRODUCTS; FLOW MEASUREMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SEWAGE; SUGAR SUBSTITUTES;

AUSTRALIA; ERROR PROPAGATION; ESTIMATED POPULATION; LC-MS/MS; NORMALIZATION;

UNCERTAINTY ANALYSIS;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACESULFAME; AMPHETAMINE; ATENOLOL; BENZOYLECGONINE; CANNABIS; COCAINE; CODEINE; ECGONINE METHYL ESTER; GABAPENTIN; HYDROCHLOROTHIAZIDE; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; MORPHINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; OPIATE; PRESCRIPTION DRUG; VENLAFAXINE;

DRUG; ERROR ANALYSIS; ESTIMATION METHOD; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PARAMETERIZATION; SAMPLING; UNCERTAINTY ANALYSIS; WASTE TREATMENT; WASTEWATER;

ARTICLE; CHEMICAL ANALYSIS; DRUG USE; EXCRETION; FLOW MEASUREMENT; HUMAN; LIQUID CHROMATOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RELIABILITY; SAMPLING; SEWAGE TREATMENT; TANDEM MASS SPECTROMETRY; WASTE WATER; WATER ANALYSIS;

CANNABIS;

EID: 79960558692     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2011.05.042     Document Type: Article

References (52)

1. Abraham T.T., Barnes A.J., Lowe R.H., Kolbrich Spargo E.A., Milman G., Pirnay S.O., Gorelick D.A., Goodwin R.S., Huestis M.A. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. J. Anal. Toxicol. 2009, 33:439-446.
2. ABS (Australian Bureau of Statistics) 4821.0.55.001 - Cardiovascular Disease in Australia: a Snapshot, 2004-05 2006, ABS, Canberra, Available. http://www.abs.gov.au/ausstats/abs@.nsf/mf/4821.0.55.001.
3. ABS (Australian Bureau of Statistics) 3201.0 - Population by Age and Sex, Australian States and Territories, Jun 2009 2009, ABS, Canberra, Available. http://www.abs.gov.au/Ausstats/abs@.nsf/mf/3201.0.
4. ACCR (Australian Crime Commission Report) Illicit Drug Data Report 2008-09 2010, Available. http://www.crimecommission.gov.au/publications/iddr/index.htm.
5. AIHW (Australian Institute of Health and Welfare) 2007 National Drug Strategy Household Survey: Detailed Findings. Drug Statistics Series No. 22. Cat. No. PHE 107 2008, AIHW, Canberra, Available. http://www.aihw.gov.au/publications/index.cfm/title/10674.
6. Ambre J., Fischman M., Ruo T. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J. Anal. Toxicol. 1984, 8:23-25.
7. Ambre J., Ruo T., Nelson J., Belknap S. Urinary excretion of cocaine, benzoylecgonine and ecgonine methyl ester in humans. J. Anal. Toxicol. 1988, 12:301-306.
8. AMH (Australian Medicines Handbook) The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, the Pharmaceutical Society of Australia and the Royal Australian College of General Practitioners. July 2010 Edition 2010, Available 1998. http://amh.hcn.net.au/view.php.
9. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Biomedical Publications, Foster City, CA. eighth ed.
10. Boleda M.R., Galceran M.T., Ventura F. Monitoring of opiates, cannabinoids and their metabolites in wastewater, surface water and finished water in Catalonia, Spain. Water Res. 2009, 43:1126-1136.
11. Boleda M.R., Galceran M.T., Ventura F. Trace determination of cannabinoids and opiates in wastewater and surface waters by ultra-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1175:38-48.
12. Bones J., Thomas K.V., Paull B. Using environmental analytical data to estimate levels of community consumption of illicit drugs and abused pharmaceuticals. J. Environ. Monit. 2007, 9:701-707.
13. Buerge I.J., Buser H.R., Kahle M., Müller M.D., Poiger T. Ubiquitous occurrence of the artificial sweetener acesulfame in the aquatic environment: an ideal chemical marker of domestic wastewater in groundwater. Environ. Sci. Technol. 2009, 43:4381-4385.
14. Castiglioni S., Zuccato E., Chiabrando C., Fanelli R., Bagnati R. Mass spectrometric analysis of illicit drugs in wastewater and surface water. Mass Spectrom. Rev. 2008, 27:378-394.
15. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2006, 78:8421-8429.
16. Chiaia A.C., Banta-Green C., Field J. Eliminating solid phase extraction with large volume injection LC/MSMS: analysis of illicit and legal drugs and human urine indicators in US wastewaters. Environ. Sci. Technol. 2008, 42:8841-8848.
17. Collins D.J., Lapsley H.M. The Costs of Tobacco, Alcohol and Illicit Drug Abuse to Australian Society in 2004/05 2008, Available, Online. http://www.health.gov.au/internet/drugstrategy/publishing.nsf/Content/34F55AF632F67B70CA2573F60005D42B/$File/mono64.pdf.
18. Cone E.J., Sampson-Cone A.H., Darwin W.D., Huestis M.A., Oyler J.M. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J. Anal. Toxicol. 2003, 27:386-401.
19. Cone E.J., Tsadik A., Oyler J., Darwin W.D. Cocaine metabolism and urinary excretion after different routes of administration. Ther. Drug Monit. 1998, 20:556-560.
20. Daughton C.G. Illicit drugs in municipal sewage: proposed new non-intrusive tool to heighten public awareness of societal use of illicit/abused drugs and their potential for ecological consequences. Pharmaceuticals and Personal Care Products in the Environment. Scientific and Regulatory Issues 2001, 348-364. American Chemical Society, Washington, DC, Symposium Series 791. C.G. Daughton, T.L. Jones-Lepp (Eds.).
21. Daughton C.G. Illicit drugs: contaminants in the environment and utility in forensic epidemiology. Rev. Environ. Contam. Toxicol. 2011, 210:59-110.
22. Degenhardt L., Hall W., Lynskey M., Warner-Smith M. Illicit drug use. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors 2004, chapter 13:1109-1176. World Health Organization, Geneva. second ed. M. Ezzati, A.D. Lopez, A. Rodgers, R. Murray (Eds.).
23. DASIS (Drug and Alcohol Services Information System) The DASIS Report: Cocaine Route of Administration Trends: 1995-2005 2007, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD, Available. http://www.oas.samhsa.gov/2k7/crackTX/crackTX.pdf.
24. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 2003, 42:327-360.
25. 14C-venlafaxine in mouse, dog, rhesus money and man. Xenobiotica 1993, 23:349-359.
26. Huerta-Fontela M., Galceran M.T., Ventura F. Ultraperformance liquid chromatography-tandem mass spectrometry analysis of stimulatory drugs of abuse in wastewater and surface waters. Anal. Chem. 2007, 79:3821-3829.
27. Huerta-Fontela M., Galceran M.T., Martin-Alonso J., Ventura F. Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci. Total Environ. 2008, 397:31-40.
28. Irvine, R.J, Kostakis, C, Felgate, P.D, Jaehne, E.J, Chen, C, White, J.M. Population drug use in Australia: a wastewater analysis. Forensic Sci. Int. in press, doi:10.1016/j.forsciint.2011.01.037.
29. Karolak S., Nefau T., Bailly E., Solgadi A., Levi Y. Estimation of illicit consumption by wastewater analysis in Paris area. Forensic Sci. Int. 2010, 200:153-160.
30. Lienert J., Gudel K., Escher B.I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ. Sci. Technol. 2007, 41:4471-4478.
31. Metcalfe C., Tindale K., Li H., Rodayan A., Yargeau V. Illicit drugs in Canadian municipal wastewater and estimates of community drug use. Environ. Pollut. 2010, 158:3179-3185.
32. Miège C., Choubert J.M., Ribeiro L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environ. Pollut. 2009, 157:1721-1726.
33. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
34. Ort C., Lawrence M.G., Reungoat J., Eaglesham G., Carter S., Keller J. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res. 2010, 44:605-615.
35. Ort C., Lawrence M.G., Reungoat J., Mueller J.F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ. Sci. Technol. 2010, 44:6289-6296.
36. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44:6024-6035.
37. Prichard J., Ort C., Bruno R., Gartner C., Kirkbride P., Hall W., Lai F.Y., Carter S., Mueller J., Salinas A. Developing a method for site-specific wastewater analysis: implications for prisons and other agencies with an interest in illicit drug use. J. Law Inf. Sci. 2010, 20:15-27.
38. Postigo C., Lopez de Alda M.J., Barcelo D. Analysis of drugs of abuse and their human metabolites in water by LC-MS/MS: a non-intrusive tool for drug abuse estimation at the community level. Trends Anal. Chem. 2008, 1053-1069.
39. Postigo C., Lopez de Alda M.J., Barcelo D. Drugs of abuse and their metabolites in the Ebro river basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environ. Int. 2010, 36:75-84.
40. Rieckermann J., Bareš V., Kracht O., Braun D., Gujer W. Estimating sewer leakage from continuous tracer experiments. Water Res. 2007, 41(9):1960-1972.
41. Shand F., Topp L., Darke S., Makkai T., Griffiths P. The monitoring of drug trends in Australia. Drug Alcohol Rev. 2003, 22:63-74.
42. Stafford J., Burns L. Australian Drug Trends 2009. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trend Series No. 37 2010, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Available. http://www.med.unsw.edu.au/NDARCWeb.nsf/page/National%2525%2520Reports.
43. Terzic S., Senta I., Ahel M. Illicit drugs in wastewater of the city of Zagreb (Croatia) - estimation of drug abuse in a transition country. Environ. Pollut. 2010, 158:2686-2693.
44. Thomann M. Quality evaluation methods for wastewater treatment plant data. Water Sci. Technol. 2008, 57(10):1601-1609.
45. UNODC (United Nations Office on Drugs and Crime) World Drug Report. Methodology 2010, Available. http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html.
46. van Nuijs A.L.N., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P.G., Bervoets L., Blust R., Neels H., Covaci A. Cocaine and metabolites in waste and surface water across Belgium. Environ. Pollut. 2009, 157:123-129.
47. van Nuijs A.L.N., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P.G., Bervoets L., Blust R., Neels H., Covaci A. Spatial and temporal variations in the occurence of cocaine and benzoylecgonine in waste- and surface water from Belgium and removal during wastewater treatment. Water Res. 2009, 43:1341-1349.
48. van Nuijs A.L.N., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P.G., Bervoets L., Blust R., Meulemans H., Neels H., Covaci A. Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium. Addiction 2009, 104:734-741.
49. van Nuijs, A.L.N., Castiglioni, S., Tarcomnicu, I., Postigo, C., de Alda, M.L., Neels, H., Zuccato, E., Barcelo, D., Covaci, A. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci. Total Environ., in press.
50. van Nuijs A.L.N., Mougel J.F., Tarcomnicu I., Bervoets L., Blust R., Jorens P.G., Neels H., Covaci A. Sewage epidemiology - a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. Environ. Int. 2011, 37:612-621.
51. Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ. Health Persp. 2008, 116:1027-1032.
52. Zuccato E., Chiabrando C., Castiglioni S., Calamari D., Bagnati R., Schiarea S., et al. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ. Health 2005, 4:14-20.